» Articles » PMID: 32571382

Defining Key Design Elements of Registry-based Randomised Controlled Trials: a Scoping Review

Overview
Journal Trials
Publisher Biomed Central
Date 2020 Jun 24
PMID 32571382
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Traditional randomised controlled trials remain the gold standard for improving clinical care but they do have their limitations, including their associated high costs, high failure rate and limited external validity. An alternative methodology is the newly defined, prospective, registry-based randomised controlled trial (RRCT), where treatment and outcome data is collected in an existing registry. This scoping review explores the current literature regarding RRCTs to help identify the key design elements of RRCTs and the characteristics of clinical registries on which they are reliant on.

Methods: A scoping review methodology conducted in accordance with the Joanna Briggs Institute guidelines was performed. Four databases were searched for articles published from inception to June 2018: Medline; Embase; the Cumulative Index to Nursing and Allied Health Literature and; Scopus. The search strategy included MeSH and text words related to RRCT.

Results: We identified 2369 articles of which 75 were selected for full-text screening. Of these, only 17 articles satisfied our inclusion criteria. All studies were published between 1996 and 2017 and all were investigator-initiated. Study designs were mainly multi-site comparative/effectiveness studies incorporating the use of disease registries (n = 8), procedure registries (n = 8) and a health services registry (n = 1). The low cost, reduced administrative burden and enhanced external validity of RRCTs make them an attractive research methodology which can be used to address questions of public health importance. We identified that that there are variable definitions of what constituted a RRCT and that issues related to ethical conduct and data integrity, completeness, timeliness, validation and endpoint adjudication need to be carefully addressed.

Conclusion: RRCTs potentially have an important role to play in informing best clinical practice and health policy. There are a number of issues that need to be addressed to optimise the utility of this approach, including establishing universally accepted criteria for the definition of a RRCT.

Citing Articles

The value of real world evidence and pragmatic trials in advanced prostate cancer- insights from the electronic Prostate Cancer Australian and Asian Database.

Anton A, Zlatic K, OHaire S, Tran B Front Oncol. 2024; 14:1494073.

PMID: 39717747 PMC: 11663904. DOI: 10.3389/fonc.2024.1494073.


A qualitative study exploring stakeholders' perceptions of registry-based randomised controlled trials capacity and capability in Australia.

Karanatsios B, Prang K, Yeung J, Gibbs P Trials. 2024; 25(1):834.

PMID: 39696640 PMC: 11654275. DOI: 10.1186/s13063-024-08668-8.


Feasibility of embedding orthopaedic clinical trials into national registries: a pilot quality improvement study for the UK Non-Arthroplasty Hip Registry (UK-NAHR).

Sohatee M, McBryde C, Andrade T, Gaston P, Hutt J, Khanduja V J Hip Preserv Surg. 2024; 11(3):216-222.

PMID: 39664203 PMC: 11631395. DOI: 10.1093/jhps/hnae018.


Use cases of registry-based randomized controlled trials-A review of the registries' contributions and constraints.

Kubesch N, Gaitonde S, Petriti U, Bakker E, Basu S, Birks L Clin Transl Sci. 2024; 17(11):e70072.

PMID: 39558508 PMC: 11573736. DOI: 10.1111/cts.70072.


Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).

Wilkinson C, Bhatty A, Batra G, Aktaa S, Smith A, Dwight J Eur Heart J. 2024; 46(2):190-214.

PMID: 39545867 PMC: 11704390. DOI: 10.1093/eurheartj/ehae724.


References
1.
Liu J, DAngelica M, Ko C . The Randomized Registry Trial: Two Birds, One Stone. Ann Surg. 2017; 265(6):1064-1065. DOI: 10.1097/SLA.0000000000002166. View

2.
Kempe A, Daley M, Barrow J, Allred N, Hester N, Beaty B . Implementation of universal influenza immunization recommendations for healthy young children: results of a randomized, controlled trial with registry-based recall. Pediatrics. 2005; 115(1):146-54. DOI: 10.1542/peds.2004-1804. View

3.
Mc Cord K, Salman R, Treweek S, Gardner H, Strech D, Whiteley W . Routinely collected data for randomized trials: promises, barriers, and implications. Trials. 2018; 19(1):29. PMC: 5765645. DOI: 10.1186/s13063-017-2394-5. View

4.
Kwakkenbos L, Juszczak E, Hemkens L, Sampson M, Frobert O, Relton C . Protocol for the development of a CONSORT extension for RCTs using cohorts and routinely collected health data. Res Integr Peer Rev. 2018; 3:9. PMC: 6205772. DOI: 10.1186/s41073-018-0053-3. View

5.
Hofmann R, James S, Jernberg T, Lindahl B, Erlinge D, Witt N . Oxygen Therapy in Suspected Acute Myocardial Infarction. N Engl J Med. 2017; 377(13):1240-1249. DOI: 10.1056/NEJMoa1706222. View